SHINEWAY PHARM (02877) Revenue Breakdown - Main Composition

9.720
-0.220-2.21%

Noon Break Apr 13 11:58 CST

8.04BMarket Cap7.64P/E (TTM)

SHINEWAY PHARM (02877) Revenue Breakdown Overview

By Business/Source

Currency:CNY

2025/FY

Stock NameRevenueRatio

Injection1.02B32.42%

Traditional Chinese medicine formula granules933.66M29.78%

Granule542.74M17.31%

Soft capsule435.86M13.90%

其他(包括丸剂及片剂等)206.69M6.59%

By Product

Currency:CNY

2025/FY

Stock NameRevenueRatio

Injection1.02B32.42%

Traditional Chinese medicine formula granules933.66M29.78%

Granule542.74M17.31%

Soft capsule435.86M13.90%

其他(包括丸剂及片剂等)206.69M6.59%

By Country/Region

Currency:CNY

2011/FY

Stock NameRevenueRatio

中国(包括中国香港)1.98B100.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"